Nurix Therapeutics, Inc.
NRIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001549595
In the last 90 days, Nurix Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 211 institutions reported holding it in 13F filings for Q2 2026, worth $2.84B in total; ARK Invest is the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Nurix Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 106 | 118 | +12 |
| Shares | 45.0M | 43.1M | −1.94M (−4.3%) |
| Value | $568.4M | $561.0M | −$7.49M (−1.3%) |
New holders (20)
Institutions that held Nurix Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 992,428 | $12.9M | 0.01% |
| Citadel Advisors LLC | 138,679 | $1.81M | 0.00% |
| BNP Paribas Arbitrage, SA | 76,415 | $995.7K | 0.00% |
| Voloridge Investment Management, LLC | 75,876 | $989.0K | 0.01% |
| D. E. Shaw & Co., Inc. | 60,014 | $782.0K | 0.00% |
| Standard Life Aberdeen plc | 30,537 | $398.0K | 0.00% |
| ExodusPoint Capital Management, LP | 25,954 | $338.0K | 0.00% |
| XTX Topco Ltd | 23,879 | $311.0K | 0.08% |
| Balyasny Asset Management LLC | 15,930 | $208.0K | 0.00% |
| Dynamic Technology Lab Private Ltd | 15,498 | $202.0K | 0.02% |
| Jacobs Levy Equity Management, Inc | 12,851 | $167.0K | 0.00% |
| HSBC Holdings PLC | 12,174 | $162.0K | 0.00% |
| Teacher Retirement System of Texas | 10,989 | $143.0K | 0.00% |
| B. Metzler seel. Sohn & Co. AG | 10,393 | $135.0K | 0.00% |
| Denali Advisors LLC | 3,600 | $47.0K | 0.02% |
| Advisor Group Holdings, Inc. | 1,000 | $13.0K | 0.00% |
| Russell Investments Group, Ltd. | 879 | $11.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 440 | $6.00K | 0.00% |
| Wipfli Financial Advisors LLC, | 67 | $1.00K | 0.00% |
| Point72 Hong Kong Ltd | 19 | $0 | 0.00% |
Sold out (8)
Institutions that held Nurix Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| TRV GP III, LLC | 1,922,549 | $24.4M |
| Eventide Asset Management, LLC | 1,154,000 | $14.6M |
| Foresite Capital Management IV, LLC | 677,143 | $8.58M |
| Bank of Montreal | 24,104 | $289.0K |
| Fred Alger Management, LLC | 7,306 | $93.0K |
| Prospera Financial Services Inc | 200 | $3.00K |
| State of Wyoming | 209 | $3.00K |
| Group One Trading, L.P. | 100 | $1.00K |